secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001664710-25-000002
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros Therapeutics updates corporate presentation for investor meetings
-----------------------------------------------------------------------

- Presentation dated January 2025 posted on company website and attached as Exhibit 99.1.
- No specific financial or clinical data disclosed in the furnished exhibit excerpt.
- Update is procedural for routine investor communications; no material news identified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000002/0001664710-25-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000002/kros-20250110.htm
  HTML page:      https://secwatch.observer/filing/0001664710-25-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer